Industry news

The Challenges and Opportunities of a Foreign Drug Registration in Russia, ARS PharmRussia Reveals

Remedium

Few foreign biotechnology & pharmaceutical companies know about real chances to win state tenders in Russia. Overcoming local challenges, they gain great opportunities in drug development.

Two pharma veterans set up a new oncology startup

GMP News

Biotech and pharmaceutical executives Robert Mulroy and Dr. Debasish Roychowdhury announced the launch of Partner Therapeutics, or PTx, an oncology company that is focused on the development and commercialization of approved and late-stage therapies. 

Roadmap for Development of Competition in Healthcare

GMP News

In December 2017 the Russian President approved the National Plan for the Development of Competition. This is a cross-industrial document which requires elaboration of sector-specific roadmaps.

Can influencer marketing work for pharma on social media? One agency thinks so

Beth Snyder Bulik / FiercePharma

Pharma companies often partner with celebrities to help spread messages and sell products. But there's a new kind of digital celebrity out there—social media influencers—that pharma has only begun to tap.

Russian scientists receive award for unique R&D in the area of oncology

GMP News

The award of the Government of the Russian Federation in the area of science and technology was given for the development, manufacturing and implementation of Russian radioactive sources for contact radiation therapy in oncology. Russian scientists, doctors, and engineers have developed radioactive sources based on iodine-125, cobalt-60 and iridium-192 for contact radiation therapy. Currently, Russia has the technology for manufacturing these sources and started their industrial production.

Do brands matter in pharma? Not as much as outcomes, patients say: study

Beth Snyder Bulik / FiercePharma

Pharma brands don’t matter nearly as much to consumers as results when it comes to new drugs, according to a new report. Accenture Life Sciences found that 69% of patients said product benefits were more important than brand. Only 25% ranked brand loyalty or popularity as a top factor in their healthcare and product and treatment decisions.

Top 10 pharma and biotech trends to watch in 2018

Chanice Henry / PharmaIQ

Pharma IQ takes a look at some of the trends forecasted to take hold this year: disruption for vendor landscapes, regulatory intervention and sophisticated analytics technologies gaining speed. 

The output of pharmaceutical products in Russia grew by 12% over the year

GMP News

Russian President Vladimir Putin held a working meeting with the Minister of Industry and Trade Denis Manturov. The Minister briefed Mr. Putin on the development of the real sector of the economy in 2017. He said that, for several years, the pharmaceutical industry was demonstrating a steady growth of more than 10 percent a year due to the timely adopted Pharma 2020 program.

Russia approves the plan for development of competition in the drug market

GMP News

The Russian Prime Minister signed a Decree approving the road map for the Development of Competition in Health Care. The plan is aimed at developing the competition on commercial markets of medicinal products, medical devices, medical services, and dietary supplements.

BIO urges more VC, R&D in neglected areas, starting with depression

Amirah Al Idrus / FierceBiotech

Over the years, the Biotechnology Innovation Organization (BIO) has noticed a slide in venture funding for some “highly prevalent, chronic diseases.” Now, BIO is releasing a series of reports calling for more work to be done in certain disease areas, starting with depression.